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Abstract
Background: The prevalence of pure stress urinary incontinence (P-SUI) and the role of urodynamic investigation
(UDI) prior to surgery for stress urinary incontinence (SUI) is debated. Since the exact prevalence of P-SUI is not
clear, its clinical and economic impact is not well defined. The aims of this study were to evaluate the prevalence
of P-SUI in a population of women who underwent UDI for urinary incontinence (UI), also assessing: 1) the
correspondence between clinical diagnosis of P-SUI and urodynamic findings; 2) the analysis of costs in terms of
UDI and eventually post-UDI avoided surgical procedures.
Methods: A single cohort of women who underwent UDI for UI between January 2012 and July 2016 was
prospectively collected and retrospectively analyzed. Clinical P-SUI was defined by the strict criteria of the
International Continence Society. For each patient, history, physical examination and UDI were collected. The
correspondence between clinical and urodynamic findings of P-SUI was analyzed. The rate of clinical P-SUI changed
after performing UDI and the number of unnecessary intervention after UDI were reported. A wide cost analysis of
UDIs, and the amount of surgical procedures that were believed unnecessary after UDI was reported.
Results: Stress urinary incontinence was present in 323/544 (59.4%) patients. The prevalence of clinical P-SUI was
20.7% (67/323), while the prevalence of complicated SUI (C-SUI) was 79.3% (256/323). After UDI, diagnosis of P-SUI
decreased to 18.3% (59/232). In 10.2% of cases (6/59) the scheduled middle urethral sling (MUS) was suppressed
after the UDI results because 3/6 cases had detrusor overactivity and urge incontinence, in 2/6 cases SUI was
treated with a conservative management, in 1/6 case an important voiding dysfunction was detected. Considering the
national reimbursement in our country, the cost of each UDI was 296.5 euros and the total amount was 17,493.5 euros.
So far the surgery-related savings covered 61.7–105.0% of the costs of total number of UDIs performed in the
uncomplicated patients.
Conclusions: The prevalence of clinical P-SUI is relevant, involving about 20% of women with clinical SUI. Although
the correspondence between clinical and urodynamic diagnosis was high, we demonstrated that UDI may help in
some cases to avoid an inappropriate surgical treatment. Therefore, UDI prior to SUI surgery should be considered to
achieve a correct diagnosis and a proper therapeutic strategy.
© The Author(s). 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
* Correspondence: emanuele.rubilotta@aovr.veneto.it
1Department of Urology, Azienda Ospedaliera Universitaria Integrata (AOUI),
Piazzale Aristide Stefani, 1, 37126 Verona, Italy
Full list of author information is available at the end of the article
Rubilotta et al. BMC Urology           (2019) 19:44 
https://doi.org/10.1186/s12894-019-0468-2
Background
Uncomplicated stress urinary incontinence (SUI), also
called pure stress urinary incontinence (PSUI), and the
role of urodynamic investigation (UDI) prior to surgery
for SUI have been under debate in the last years [1–3].
Since the exact prevalence of P-SUI is not clear, its
clinical and economic impact is even not well defined. It
has been calculated that in women with uncomplicated
SUI and a confirmatory preoperative basic office
evaluation, from 13 to 33 millions of US dollars could
be saved annually by not performing UDI test [4].
Nevertheless, other authors reported that savings ob-
tained by not performing UDI in these patients seem
to be moderate [5].
Considering the cost of a single UDI, it has been
debated if it is useful in women with uncomplicated SUI
prior to surgical correction. Few papers showed that an
office evaluation is a sufficient work-up for women with
uncomplicated SUI, since their incontinence surgery
outcomes were not inferior if compared to women who
underwent UDI [6, 7]. However, the correlation between
real prevalence of uncomplicated SUI and costs of
clinical evaluation, UDI and surgical treatment has never
been systematically analysed.
The aim of our study was to evaluate the prevalence of
clinical P-SUI in a population of women who underwent
UDI for urinary incontinence (UI), assessing the corres-
pondence between clinical diagnosis of P-SUI and uro-
dynamic stress incontinence. Our secondary end-point
was to analyze the costs of UDI in women with P-SUI,
and the number of surgical procedures that were
believed unnecessary after UDI, including related money
savings.
Methods
A single cohort of women who underwent UDI for UI
between January 2012 and July 2016 was prospectively
collected and retrospectively analyzed. Data were ob-
tained from an electronic database. Urodynamic tests
were performed according to the Good Urodynamic
Practice [7]. P-SUI was defined by the International
Continence Society (ICS) criteria. All women with
clinical P-SUI had no history of: (i) previous pelvic surgi-
cal treatments; (ii) pain; (iii) aematuria; (iiii) recurrent
infections; (iiiii) voiding symptoms; (iiiiii) pelvic irradi-
ation; (iiiiiii) suspected fistula. Inclusion criteria were:
naive patients for SUI without pelvic organ prolapse.
All women underwent UDI and their data were
assessed by a urologist skilled in UDI and female
urology. For all the patients, the first evaluation was
obtained in the outpatient clinic recording patient’s
history and physical exam. Though the history, the
clinician assessed the prevalent type of incontinence and
its duration, moreover urinalysis and urine culture were
analyzed. The physical exam included abdominal, pelvic
and vaginal examination, a stress test (with an ultra-
sound estimated bladder volume of 200 ml, and if
negative with a bladder volume of 300ml) and uroflow-
metry with post-voiding residual volume [8]. Then, in
case of sterile urine culture, a UDI was performed.
Finally, the correspondence between clinical and urody-
namic stress incontinence was evaluated.
UDI findings were compared with clinical data and the
results were considered different when a UDI outcome
was not correspondent to the pre-UDI expected clinical
data. Clinical P-SUI was not confirmed when at least
one of the following UDI observations was found: i)
mixed urinary incontinence with predominant detrusor
overactivity; ii) detrusor underactivity; iii) voiding
dysfunction. Patients were considered to have a detrusor
underactivity when Qmax was ≤12ml/sec and Pdet/
Qmax was ≤10 cmH2O [9]. Women were classified as
having voiding dysfunction when Qmax was ≤12 ml/sec
and Pdet/Qmax was ≥25 cmH2O [10, 11]. Depending
on UDI results, surgical treatment options were
discussed. Patients who had a change in the treatment
strategy due to UDI results were recorded.
The exact cost of a single UDI was calculated with the
support of the Clinical Management Department. The
cost analysis included the human resources (one medical
doctor and one nurse for each UDI) and all the materials
used during the test. An additional economical evalu-
ation was performed considering the National Health
System reimbursement. Moreover, we calculated the
total amount of expenses saved by not performing the
scheduled surgical procedures of middle urethral sling
(MUS) positioning, because they were believed unneces-
sary according to UDI results.
Results
Clinical SUI was diagnosed in 323/544 (59.4%) pa-
tients. Prevalence of clinical P-SUI was 20.7% (67/
323), while prevalence of complicated SUI (C-SUI)
was 79.3% (256/323).
After UDI, diagnosis of P-SUI decreased to 18.3% (59/
323). In 11.9% (8/67) of patients diagnosis of clinical
P-SUI was not confirmed due to the detection of
predominant detrusor overactivity (3 cases), detrusor
underactivity (4 cases), and voiding dysfunction (1 case).
In 8.96% of cases (6/67) the scheduled MUS was
cancelled because of UDI results. In 3/6 patients de-
trusor overactivity and urge incontinence were detected,
in 2/6 patients SUI was treated by pelvic floor rehabilita-
tion, in 1/6 case an important voiding dysfunction was
detected. Results are better shown in Fig. 1, which
reports patients characteristics based on clinical and
UDI diagnoses and details about surgical UI correction
cancelled after UDI.
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Being the Italian National Health System reimburse-
ment for each UDI 296.5 €, the total cost for the 59
uncomplicated patients in our series was 17,493.5 €. If
we consider a reimbursement by our National Health
System ranging 1800–3073 € for each surgical procedure
for female SUI (depending from the setting – Day
Surgery or hospitalization for two or more days), the
total amount saved thanks to UDI findings ranged
10,800–18,438 €. These savings cover 61.7–105.0% of
the costs for total number of UDIs performed in the
uncomplicated patients in our series.
Discussion
In the literature few data are available on P-SUI with a
prevalence ranging from 5.2 to 36% [1, 2, 12, 13]
(Table 1). In our series, prevalence was about 20%,
aligned with the results reported by Jeong [13].
Some authors believe that the high prevalence of
P-SUI could be secondary to restricted clinical skills [3].
For this reason, our lower rate might be related to a
higher expertise in the field of urodynamics and female
urology. Furthermore, this know-how could also explain
the high correspondence between UDI findings and
clinical data which is a relevant controversial topic in
the literature (Table 1).
Some patients experienced a change in their
therapeutic strategy after UDI, leading to a significant
reduction of unnecessary surgical procedures (8.96%).
Reversely, many women would have undergone an
inappropriate surgical treatment (MUS) in case they did
not perform UDI prior to surgery. Our results are
aligned to those of Serati et al. who modified or
cancelled the planned SUI surgery in 9.7 and 9.5% of
cases, respectively [2].
In 2010, 260,000 MUS were implanted in the USA. If
we consider a prevalence of clinical P-SUI of 20.7%
(according to our study), we can therefore estimate that
around 52,000 women underwent a MUS for P-SUI
surgical correction [14]. Among these patients, almost
4659 (8.96%) might have undergone an unnecessary
surgery if the UDI had not been administered before
surgical treatment.
Thus, the issue of unnecessary surgical procedures
seems to represent a major clinical and economic topic.
Re-intervention rates related to voiding dysfunction or
to mesh extrusion have been reported in 3.7% of
cases [15]. Although with the limitations of this ana-
lysis, if we match such data with our results, an esti-
mated number of 172 women may have experienced
these complications due to an unnecessary surgical
Fig. 1 Patients stratification based on clinical and urodynamic diagnoses, including their impact on surgical indications. (Legend: UDI: urodynamic
investigation; UI, urinary incontinence; C-SUI: clinical stress urinary incontinence; P-SUI: pure stress urinary incontinence)
Table 1 Pure stress urinary incontinence (P-SUI) prevalence, correspondence between clinical PSUI and urodynamic findings, and
avoided surgery after urodynamic testing
P-SUI prevalence Correspondence Avoided surgery
W. Agur et al., 2008 5.2% – –
S.J. Jeong et al., 2012 [13] 20.7% 79.1% –
C.W. Nager et al., 2012 [1] 34% 43.2% 5.4%
M. Serati et al., 2015 36% 37.8% 9.5%
E. Rubilotta et al., 2019 20.7% 81.7% 8.96%
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treatment. Moreover, considering the reported chronic
pain rate of 4.1% after MUS, the estimated number of
patients with this potential complication after an
unnecessary surgery would be around 191. Consider-
ing literature data, 740 mesh removal procedures have
been reported in peer-reviewed publications and 7654
meshes were removed in patients presenting with
sling complications, thus leading to a total of 8394
complicated women after MUS [15]. Just in order to
extend the analysis, if we apply our criteria to the
population of the cited study [14], we confirmed the
previously reported results: 1738 patients were sup-
posed to have P-SUI and in 156 of cases the SUI
surgical intervention could have been cancelled after
UDI. These results would be even higher if we refer
to the greater P-SUI prevalence reported by the other
authors [1, 2].
In the light of these considerations, we believe that
UDI may help in the clinical diagnostic process of all
women presenting with SUI and not only in the compli-
cated ones. Indeed, UDI might help to rule out unneces-
sary surgical treatments and their potential sequelae.
Cost analysis must contemplate both direct and indir-
ect costs. The direct costs comprehend the total amount
for a single UDI, for the surgical procedure, and for
hospitalization. The negative externalities are those costs
that occur in the complicated patients, including
repeated UDI, use of devices, and potentially a new
surgical treatment and hospitalization. Our estimated
rate of unnecessary surgical treatment was 8.96%, mean-
ing that without UDI these women would have had their
insurance/health care to pay for their surgery without a
confirmed indication. Nevertheless, insurance/health
care would have paid even for the costs of the manage-
ment of negative externalities.
In our study, we performed an analysis of the direct
costs in a cohort of women with P-SUI. Analyzing the
savings from the total number of UDIs performed in the
uncomplicated patients in our series we found that costs
of avoided surgical treatment covered the amount of
money necessary for the UDIs. Regarding negative exter-
nalities, a complete cost evaluation should also include
the potential legal actions due to complications after
unnecessary interventions.
A limitation of our study may be related to the retro-
spective design, however all the data required were avail-
able for the analysis. A second limitation may be related
to the different evaluations of the costs in diverse geo-
graphical areas.
Conclusions
The prevalence of clinical P-SUI is relevant, involving 1/
5 of women with clinical SUI. The correspondence
between clinical and urodynamic diagnosis is high.
Nevertheless, in some patients an inappropriate treat-
ment was avoided basing on urodynamic results.
Although UDI involves an economic burden, its role
should be emphasized. Indeed, according to our data,
UDI prior to SUI surgery is useful to avoid unnecessary
surgical procedures and this finding should be taken into
account when calculating the real costs/savings about
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